The polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs; CD16− CD14− CD11b+ CD33+) play an important role in immune inhibition in the cancer microenvironment, while their role in circulation is still unclear. This evidence concerns the gene CD33 and cancer.